139 related articles for article (PubMed ID: 26479144)
21. Autologous c-Kit+ Mesenchymal Stem Cell Injections Provide Superior Therapeutic Benefit as Compared to c-Kit+ Cardiac-Derived Stem Cells in a Feline Model of Isoproterenol-Induced Cardiomyopathy.
Taghavi S; Sharp TE; Duran JM; Makarewich CA; Berretta RM; Starosta T; Kubo H; Barbe M; Houser SR
Clin Transl Sci; 2015 Oct; 8(5):425-31. PubMed ID: 25684108
[TBL] [Abstract][Full Text] [Related]
22. Skeletal myoblast transplantation: no MAGIC bullet for ischemic cardiomyopathy.
Eisen HJ
Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):520-1. PubMed ID: 18648335
[TBL] [Abstract][Full Text] [Related]
23. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.
Hare JM; Fishman JE; Gerstenblith G; DiFede Velazquez DL; Zambrano JP; Suncion VY; Tracy M; Ghersin E; Johnston PV; Brinker JA; Breton E; Davis-Sproul J; Schulman IH; Byrnes J; Mendizabal AM; Lowery MH; Rouy D; Altman P; Wong Po Foo C; Ruiz P; Amador A; Da Silva J; McNiece IK; Heldman AW; George R; Lardo A
JAMA; 2012 Dec; 308(22):2369-79. PubMed ID: 23117550
[TBL] [Abstract][Full Text] [Related]
24. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
Liu C; Hou Y; Wang X; Zhao Z; Liu Z; Zhai J; Mao J; Shang H
Trials; 2015 May; 16():222. PubMed ID: 25994188
[TBL] [Abstract][Full Text] [Related]
25. The reverse remodeling effect of mesenchymal stem cells is independent from the site of epimyocardial cell transplantation.
Arsalan M; Dhein S; Aupperle H; Rastan AJ; Barten MJ; Walther T; Mohr FW; Garbade J
Innovations (Phila); 2013; 8(6):433-9. PubMed ID: 24225815
[TBL] [Abstract][Full Text] [Related]
26. Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function: Results of the MESAMI 1 pilot trial.
Guijarro D; Lebrin M; Lairez O; Bourin P; Piriou N; Pozzo J; Lande G; Berry M; Le Tourneau T; Cussac D; Sensebe L; Gross F; Lamirault G; Huynh A; Manrique A; Ruidavet JB; Elbaz M; Trochu JN; Parini A; Kramer S; Galinier M; Lemarchand P; Roncalli J
Int J Cardiol; 2016 Apr; 209():258-65. PubMed ID: 26901787
[TBL] [Abstract][Full Text] [Related]
27. The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: study protocol for a randomized controlled trial.
Leone AM; D'Amario D; Teofili L; Basile E; Cannata F; Graziani F; Marzilli M; Russo AM; Tarantini G; Ceconi C; Leone G; Trani C; Rebuzzi AG; Crea F
Trials; 2016 Feb; 17():97. PubMed ID: 26891753
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous, transendocardial injection of bone marrow-derived mononuclear cells in heart failure patients following acute ST-elevation myocardial infarction: ALSTER-Stem Cell trial.
Heeger CH; Jaquet K; Thiele H; Zulkarnaen Y; Cuneo A; Haller D; Kivelitz D; Schmidt T; Krause K; Metzner A; Schneider C; Kuck KH; Bergmann MW
EuroIntervention; 2012 Oct; 8(6):732-42. PubMed ID: 23086792
[TBL] [Abstract][Full Text] [Related]
29. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.
Assmus B; Walter DH; Seeger FH; Leistner DM; Steiner J; Ziegler I; Lutz A; Khaled W; Klotsche J; Tonn T; Dimmeler S; Zeiher AM
JAMA; 2013 Apr; 309(15):1622-31. PubMed ID: 23592107
[TBL] [Abstract][Full Text] [Related]
30. Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging.
Nagao M; Matsuo Y; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Abe K; Mukai Y; Higo T; Yabuuchi H; Takemura A; Yoshiura T; Sunagawa K; Honda H
Am J Cardiol; 2014 Mar; 113(6):1024-30. PubMed ID: 24461766
[TBL] [Abstract][Full Text] [Related]
31. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics.
Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A
J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246
[TBL] [Abstract][Full Text] [Related]
32. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit
Bolli R; Hare JM; March KL; Pepine CJ; Willerson JT; Perin EC; Yang PC; Henry TD; Traverse JH; Mitrani RD; Khan A; Hernandez-Schulman I; Taylor DA; DiFede DL; Lima JAC; Chugh A; Loughran J; Vojvodic RW; Sayre SL; Bettencourt J; Cohen M; Moyé L; Ebert RF; Simari RD;
Circ Res; 2018 Jun; 122(12):1703-1715. PubMed ID: 29703749
[TBL] [Abstract][Full Text] [Related]
33. Characterization of dysfunctional remote myocardium in left ventricular anterior aneurysms and improvements following surgical ventricular restoration using cardiac magnetic resonance imaging: preliminary results.
Adhyapak SM; Menon PG; Parachuri VR; Shetty DP; Fantini F
Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):368-74. PubMed ID: 24907238
[TBL] [Abstract][Full Text] [Related]
34. Controlled study of myocardial recovery after interval training in heart failure: SMARTEX-HF--rationale and design.
Støylen A; Conraads V; Halle M; Linke A; Prescott E; Ellingsen Ø
Eur J Prev Cardiol; 2012 Aug; 19(4):813-21. PubMed ID: 21450567
[TBL] [Abstract][Full Text] [Related]
35. Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.
Vrtovec B; Poglajen G; Lezaic L; Sever M; Domanovic D; Cernelc P; Socan A; Schrepfer S; Torre-Amione G; Haddad F; Wu JC
Circ Res; 2013 Jan; 112(1):165-73. PubMed ID: 23065358
[TBL] [Abstract][Full Text] [Related]
36. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
[TBL] [Abstract][Full Text] [Related]
37. Intracoronary autologous cardiac progenitor cell transfer in patients with hypoplastic left heart syndrome: the TICAP prospective phase 1 controlled trial.
Ishigami S; Ohtsuki S; Tarui S; Ousaka D; Eitoku T; Kondo M; Okuyama M; Kobayashi J; Baba K; Arai S; Kawabata T; Yoshizumi K; Tateishi A; Kuroko Y; Iwasaki T; Sato S; Kasahara S; Sano S; Oh H
Circ Res; 2015 Feb; 116(4):653-64. PubMed ID: 25403163
[TBL] [Abstract][Full Text] [Related]
38. Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.
Collins J; Sommerville C; Magrath P; Spottiswoode B; Freed BH; Benzuly KH; Gordon R; Vidula H; Lee DC; Yancy C; Carr J; Markl M
Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552491
[TBL] [Abstract][Full Text] [Related]
39. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation.
Ling LH; Taylor AJ; Ellims AH; Iles LM; McLellan AJ; Lee G; Kumar S; Lee G; Teh A; Medi C; Kaye DM; Kalman JM; Kistler PM
Heart Rhythm; 2013 Sep; 10(9):1334-9. PubMed ID: 23811081
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stromal cells improve cardiac function and left ventricular remodeling in a heart transplantation model.
Montanari S; Dayan V; Yannarelli G; Billia F; Viswanathan S; Connelly KA; Keating A
J Heart Lung Transplant; 2015 Nov; 34(11):1481-8. PubMed ID: 26234284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
